Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andreas Diefenbach0
David H. Raulet0
Date of Patent
August 21, 2007
0Patent Application Number
110571050
Date Filed
February 11, 2005
0Patent Primary Examiner
Patent abstract
Neoplasia is treated by administering to a mammalian host a composition comprising ligands for the NKG2D receptor. In addition, other NKG2D ligands, proteins specific for the neoplastic cells and cytokines may be included to enhance the immune response. The composition may be cells comprising expression constructs for the ligands, liposomes or combinations of protein molecules.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.